Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

China Biologic Products Holdings Inc. (CBPO)

111.14   -0.12 (-0.11%) 09-30 18:47
Open: 111.7 Pre. Close: 111.26
High: 112.11 Low: 110.77
Volume: 86,822 Market Cap: 4,288M
China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. The company is headquartered in Beijing, Beijing and currently employs 2,187 full-time employees. The firm is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. The company operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 111.874 - 112.304 112.304 - 112.798
Low: 109.423 - 109.891 109.891 - 110.43
Close: 110.323 - 111.071 111.071 - 111.932

Technical analysis

as of: 2020-09-30 4:39:39 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 131.90     One year: 154.06
Support: Support1: 107.77    Support2: 104.58
Resistance: Resistance1: 112.93    Resistance2: 131.90
Pivot: 109.48
Moving Average: MA(5): 110.89     MA(20): 108.95
MA(100): 107.59     MA(250): 111.23
MACD: MACD(12,26): 1.19     Signal(9):
Stochastic oscillator: %K(14,3): 72.96     %D(3): 71.41
RSI: RSI(14): 62.90
52-week: High: 119.44  Low: 97.91  Change(%): -3.3
Average Vol(K): 3-Month: 9880  10-Days: 9628

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CBPO has closed below upper band by 30.3%. Bollinger Bands are 70% wider than normal. The large width of the bands suggest high volatility as compared to CBPO's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Mon, 21 Sep 2020
Luckin Stock Has Lots of Troubles, Sean Shao Looks to Be the Solution - InvestorPlace

Sat, 19 Sep 2020
China Biologic Products (NASDAQ:CBPO) Stock Rating Upgraded by BidaskClub - MarketBeat

Thu, 17 Sep 2020
Analyst Rating: Will China Biologic Products Holdings Inc (CBPO) Stock Outperform the Market? - InvestorsObserver

Tue, 15 Sep 2020
Is China Biologic Products Holdings Inc (CBPO) Stock About to Get Hot Tuesday? - InvestorsObserver

Mon, 14 Sep 2020
Is China Biologic Products Holdings Inc (CBPO) Stock a Smart Investment? - InvestorsObserver

Tue, 18 Aug 2020
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 39
Shares Float (M) 13
% Held by Insiders 54.17
% Held by Institutions 40.49
Shares Short (K) 457
Shares Short P. Month (K) 484

Stock Financials

EPS 3.790
EPS Est This Year 4.930
EPS Est Next Year 5.550
Book Value (p.s.) 46.120
Profit Margin 29.01
Operating Margin 35.61
Return on Assets (ttm) 5.7
Return on Equity (ttm) 9.4
Qtrly Rev. Growth -18.1
Gross Profit (p.s.) 8.530
Sales Per Share 13.270
EBITDA (p.s.) 5.424
Qtrly Earnings Growth -14.30
Operating Cash Flow (M) 271
Levered Free Cash Flow (M) 208

Stock Valuations

PE Ratio 29.34
PEG Ratio
Price to Book value 2.41
Price to Sales 8.38
Price to Cash Flow 15.85

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.